| abstract |
The present invention relates to pharmaceutical compositions and methods of treating cancer in a subject, the method comprising administering to the subject a combination therapy comprising administering (1) at least one anti-cancer therapy, and (2) a pharmaceutical composition comprising a pharmaceutically acceptable carrier and an amount of an IL-1α inhibitor, wherein the combination therapy is effective to reduce at least one symptom of the cancer in the subject. |